Your browser doesn't support javascript.
loading
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates.
Olivier, Jonathan; Stavrinides, Vasilis; Kay, Jonathan; Freeman, Alex; Pye, Hayley; Ahmed, Zeba; Carmona Echeverria, Lina; Heavey, Susan; Simmons, Lucy A M; Kanthabalan, Abi; Arya, Manit; Briggs, Tim; Barratt, Dean; Charman, Susan C; Gelister, James; Hawkes, David; Hu, Yipeng; Jameson, Charles; McCartan, Neil; Punwani, Shonit; van der Muelen, Jan; Moore, Caroline; Emberton, Mark; Ahmed, Hashim U; Whitaker, Hayley C.
  • Olivier J; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Stavrinides V; Department of Urology, Hospital Huriez, University Lille Nord de France, Lille, France.
  • Kay J; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Freeman A; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Pye H; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Ahmed Z; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Carmona Echeverria L; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Heavey S; Department of Pathology, UCLH NHS Foundation Trust, London, United Kingdom.
  • Simmons LAM; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Kanthabalan A; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Arya M; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Briggs T; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Barratt D; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Charman SC; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Gelister J; Molecular Diagnostics and Therapeutics Group, Charles Bell House, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Hawkes D; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Hu Y; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Jameson C; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.
  • McCartan N; Faculty of Medical Sciences, Division of Surgery and Interventional Science, University College London, London, United Kingdom.
  • Punwani S; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.
  • van der Muelen J; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.
  • Moore C; Department of Urology, UCLH NHS Foundation Trust, London, United Kingdom.
  • Emberton M; Department of Urology, The Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Ahmed HU; Department of Computer Science, Centre for Medical Imaging and Computing, University College London, London, United Kingdom.
  • Whitaker HC; Clinical Effectiveness Unit, The Royal College of Surgeons of England, London, United Kingdom.
Prostate ; 78(16): 1229-1237, 2018 12.
Article en En | MEDLINE | ID: mdl-30073682
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Biomarcadores de Tumor Límite: Humans / Male Idioma: En Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Próstata / Neoplasias de la Próstata / Biomarcadores de Tumor Límite: Humans / Male Idioma: En Año: 2018 Tipo del documento: Article